FDA Declines Approval for Omecamtiv Mecarbil in HFrEF ...Middle East

Citing a lack of efficacy data, the FDA has declined to approve omecamtiv mecarbil (Cytokinetics) for treatment of adults with chronic heart failure with reduced ejection fraction. News Alerts

Hence then, the article about fda declines approval for omecamtiv mecarbil in hfref was published today ( Wednesday 01/03/2023 - 10:57 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Declines Approval for Omecamtiv Mecarbil in HFrEF )

Also on site :

• Natural gas line rupture stops traffic on 5 Freeway in Castaic
• 30–35 terrorists on radar: Army steps up counterterror ops in J&K; intense vigil amid 'Chillai Kalan'
• SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model